| Angelman syndrome: a journey through the brain C Maranga, TG Fernandes, E Bekman, ST da Rocha The FEBS journal 287 (11), 2154-2175, 2020 | 41 | 2020 |
| The sigma-1 receptor mediates pridopidine rescue of mitochondrial function in Huntington disease models L Naia, P Ly, SI Mota, C Lopes, C Maranga, P Coelho, N Gershoni-Emek, ... Neurotherapeutics 18, 1017-1038, 2021 | 35 | 2021 |
| Mitochondrial and redox modifications in early stages of Huntington's disease C Lopes, IL Ferreira, C Maranga, M Beatriz, SI Mota, J Sereno, ... Redox biology 56, 102424, 2022 | 15 | 2022 |
| Generation and characterization of induced pluripotent stem cell line (IBBISTi004-A) from an Angelman syndrome patient carrying a class II deletion of the maternal chromosome … C Maranga, C Pereira, AC Raposo, A Vieira, S Duarte, EP Bekman, ... Stem Cell Research 61, 102757, 2022 | 1 | 2022 |
| Induced pluripotent stem cells for modeling Angelman syndrome C Maranga, AA Vieira, EP Bekman, ST Da Rocha iPSCs for Modeling Central Nervous System Disorders, 217-238, 2021 | 1 | 2021 |
| Pridopidine Rescues Multiple Mitochondrial Functions Impaired in Human and Mouse HD Models by Activation of the Sigma-1 Receptor M Geva, L Naia, P Ly, C Lopes, SI Mota, C Maranga, M Hayden, AC Rego NEUROTHERAPEUTICS 16 (4), 1361-1361, 2019 | | 2019 |
| Pridopidine improves overall mitochondrial function in cellular models of Huntington's disease L Naia, C Maranga, C Lopes, M Geva, M Hayden, A Cristina Rego EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 48, 55-55, 2018 | | 2018 |
| Early mitochondrial modifications in YAC128 transgenic model of Huntington’s disease CSB Maranga | | 2016 |
